Harpoon Therapeutics Announces Presentation on HPN328 at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 22, 2019 16:05 ET
|
Harpoon Therapeutics
SOUTH SAN FRANCISCO, Calif., Oct. 22, 2019 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today...
Bills.com Report Evaluates Changes to HARP Program
November 21, 2011 08:06 ET
|
Bills.com
SAN MATEO, CA--(Marketwire - Nov 21, 2011) - Consumer money resource Bills.com today released a consumer-focused evaluation and primer on the recently updated Home Affordability Refinance Program...